Anti-inflammatory medicines are prescribed to treat disorders such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others. The rising prevalence of chronic disorders is the primary driver of market growth. Although documented side effects and the expiration of patents on blockbuster drugs are limiting market growth, new research advancements in anti-inflammatory biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs), and other areas are helping to make this class of drugs as side effect free as possible while maintaining efficacy and potency.
Furthermore, the overall Anti-inflammatory Drugs Market is projected to be driven by rising awareness of anti-inflammatory therapies and appealing government programmes.
Read more @ https://cmilatestinsights.blogspot.com/2022/02/anti-inflammatory-drugs-market-size.html
